Healthcare Realty Trust Inc
For the period ended Sep 30, 2024. Filed Oct 30, 2024.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 30, 2024 · Filed Oct 30, 2024
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Consolidated Statements of Operations
For the Three and Nine Months Ended September 30, 2024 and 2023
| THREE MONTHS ENDED September 30, | NINE MONTHS ENDED September 30, | |||
|---|---|---|---|---|
| 2024 | 2023 | 2024 | 2023 | |
| Revenues | ||||
| Rental income | $306,499 | $333,335 | $932,710 | $987,109 |
| Interest income | 3,904 | 4,264 | 12,307 | 12,711 |
| Other operating | 5,020 | 4,661 | 13,533 | 13,508 |
| 315,423 | 342,260 | 958,550 | 1,013,328 | |
| Expenses | ||||
| Property operating | 120,232 | 131,639 | 359,030 | 379,074 |
| General and administrative | 20,124 | 13,396 | 48,913 | 43,796 |
| Transaction costs | 719 | 769 | 1,545 | 1,725 |
| Merger-related costs | — | 7,450 | — | (3,366) |
| Depreciation and amortization | 163,226 | 182,989 | 514,821 | 550,661 |
| 304,301 | 336,243 | 924,309 | 971,890 | |
| Other income (expense) | ||||
| Gain on sales of real estate properties and other assets | 39,310 | 48,811 | 77,670 | 56,974 |
| Interest expense | (60,649) | (66,304) | (184,159) | (195,397) |
| Gain on extinguishment of debt | — | 62 | — | 62 |
| Impairment of real estate properties and credit loss reserves | (84,394) | (56,873) | (232,450) | (143,510) |
| Impairment of goodwill | — | — | (250,530) | — |
| Equity income (loss) from unconsolidated joint ventures | 208 | (456) | (360) | (1,253) |
| Interest and other (expense) income, net | (132) | 139 | (104) | 1,278 |
| (105,657) | (74,621) | (589,933) | (281,846) | |
| Net loss | $(94,535) | $(68,604) | $(555,692) | $(240,408) |
| Net loss attributable to non-controlling interests | 1,512 | 760 | 8,053 | 2,680 |
| Net loss attributable to common stockholders | $(93,023) | $(67,844) | $(547,639) | $(237,728) |
| Basic earnings per common share | $(0.26) | $(0.18) | $(1.49) | $(0.63) |
| Diluted earnings per common share | $(0.26) | $(0.18) | $(1.49) | $(0.63) |
| Weighted average common shares outstanding - basic | 358,960 | 378,925 | 370,254 | 378,886 |
| Weighted average common shares outstanding - diluted | 358,960 | 378,925 | 370,254 | 378,886 |
The accompanying notes, together with the Notes to the Consolidated Financial Statements included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2023, are an integral part of these financial statements.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.